From Radiation Osteitis to Osteoradionecrosis: Incidence and MR Morphology of Radiation-induced Sacral Pathologies Following Pelvic Radiotherapy
Overview
Affiliations
Objective: To investigate the incidence rate, time-to-onset and recovery, MRI morphology and occurrence of insufficiency fractures in radiation-induced changes in the sacrum following pelvic radiotherapy.
Material And Methods: 410 patients with pelvic malignancies treated with radiotherapy were reviewed. Follow-up was 1-124 months (mean 22 months). Serial MRI (average four studies/patient) were analysed using a new semi-quantitative score (Radiation-Induced Sacral Changes=RISC). A size category (I/II/III), a type category for MR signal morphologies (a/b/c) and sacral insufficiency fractures (+/-) were applied.
Results: Seventy-two patients (17.6 %) were found to have new pathological signal changes. Radiation osteitis was documented in 83.3 % (60/72, RISC stage a + b), and definite osteonecrosis (stage c) in 12 patients (16.7 %, 12/72). Thirty-one patients (43.1 %) had sacral insufficiency fractures. Initial bone marrow signal changes were found 1-35 months (median 4 months) after radiotherapy. The maximum manifestation of radiation-induced signal changes occurred after 1-35 months (mean 11 months). Fifty-six cases (77.8 %) showed a significant signal recovery within 16.5 months.
Conclusion: Radiation-induced bone marrow changes appear with a high incidence at the sacrum with an early onset and frequent recovery. The majority presented a pattern of radiation osteitis, whereas osteoradionecrosis was proportionately rare.
Key Points: • Radiation-induced sacral bone marrow changes appear frequently (17.6 %) following pelvic radiotherapy. • Insufficiency fractures are common late effects (43 %). • Radiation osteitis develops early (4 mo), with recovery between 16.5 and 39.5 months. • Definite radiological osteoradionecrosis is proportionately rare (3 %). • A 3-stage classification system simplifies and standardizes the morphological disease staging.
Magnusson P, Saaf M, Martling A, Svanstrom Rojvall A, Atanasova D, Wilamowski F JBMR Plus. 2024; 8(9):ziae087.
PMID: 39108362 PMC: 11299508. DOI: 10.1093/jbmrpl/ziae087.
Review of the Pathogenesis, Diagnosis, and Management of Osteoradionecrosis of the Femoral Head.
Li Y, Zhou Z, Xu S, Jiang J, Xiao J Med Sci Monit. 2023; 29:e940264.
PMID: 37310931 PMC: 10276533. DOI: 10.12659/MSM.940264.
Lu Y, Chen C, Chen S, Lin C, Lin Y, Lin C Cancers (Basel). 2023; 15(8).
PMID: 37190268 PMC: 10136633. DOI: 10.3390/cancers15082339.
Vijayakumar G, Jones C, Supple S, Meyer J, Blank A Skeletal Radiol. 2023; 52(9):1747-1754.
PMID: 37052652 DOI: 10.1007/s00256-023-04338-z.
Guo H, Zhang Z, Wang L, Yao S, Xu S, Ma S Contrast Media Mol Imaging. 2022; 2022:7717398.
PMID: 36247843 PMC: 9532126. DOI: 10.1155/2022/7717398.